Poland· PL-100203585

Synflorix

A pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert product containing szczepionka przeciw pneumokokom, registered in Poland by GlaxoSmithKline Biologicals S.A.. The same ATC class is registered in 8 of our 19 countries.

ATC J07AL52

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSynflorixATCJ07AL52REGISTER NO.PL-100203585PACKS LISTED9CHECKEDSeptember 27, 2026

Where it is registered

Pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert is registered in 8 of 19 countries.

Countries holding a registration under ATC J07AL52 (pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose

Pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert · ATC J07AL52

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Szczepionka przeciw pneumokokom
Manufacturer
GlaxoSmithKline Biologicals S.A.
Country
Poland (PL)
ATC code
J07AL52
ATC class
Pneumokokken, gereinigtes Polysaccharid-Antigen und Haemophilus influenzae B, konjugiert
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 9

  • gtin
    05909990678099
  • gtin
    05909990198214
  • gtin
    05909990678068
  • gtin
    05909990678075
  • gtin
    05909990678082
  • gtin
    05909990678105
  • gtin
    05909990678112
  • gtin
    05909990678129
  • gtin
    05909990678136

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f15efba5-909c-4d55-a7be-b6e84e34c24e
GET /v1/drugs/f15efba5-909c-4d55-a7be-b6e84e34c24e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Zawiesina do wstrzykiwań",
  "source": "urpl",
  "strength": null,
  "packaging": "05909990678099 ¦ Rp ¦ EU/1/09/508/005 ¦ 47791\n1 amp.-strzyk. 0,5 ml ¦ 2 igły \n05909990198214 ¦ Rp ¦ EU/1/09/508/001 ¦ 47893\n1 amp.-strzyk. 0,5 ml\n05909990678068 ¦ Rp ¦ EU/1/09/508/002 ¦ 47894\n10 amp.-strzyk. 0,5 ml\n05909990678075 ¦ Rp ¦ EU/1/09/508/003 ¦ 47895\n1 amp.-strzyk. 0,5 ml ¦ 1 igła \n05909990678082 ¦ Rp ¦ EU/1/09/508/004 ¦ 47896\n10 amp.-strzyk. 0,5 ml ¦ 10 igieł \n05909990678105 ¦ Rp ¦ EU/1/09/508/006 ¦ 47898\n1 fiol. 0,5 ml\n05909990678112 ¦ Rp ¦ EU/1/09/508/007 ¦ 47899\n10 fiol. 0,5 ml\n05909990678129 ¦ Rp ¦ EU/1/09/508/008 ¦ 47900\n100 fiol. 0,5 ml\n05909990678136 ¦ Rp ¦ EU/1/09/508/009 ¦ 47901\n100 fiol. 1 ml\nRp ¦ EU/1/09/508/010 ¦ 106110\n50 amp.-strzyk. 0,5 ml\nRp ¦ EU/0/00/000/012 ¦ 126069\n10 fiol. 2 ml\nRp ¦ EU/0/00/000/013 ¦ 126070\n100 fiol. 2 ml",
  "substance": null,
  "common_name": "Szczepionka przeciw pneumokokom",
  "pl_product_id": "100203585",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}

See everything about pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.